OPA1 and autosomal dominant optic atrophy: Patients carrying mutations affecting the inner mitochondrial membrane fusion protein, OPA1, associated with Autosomal Dominant Optical Atrophy (ADOA), are characterized by early-onset blindness and develop late-onset myopathy (4) and altered muscle mitochondrial ATP synthesis (5).